Alana B. McNulty

Insider Reports History

Entity
Individual
Location
C/O Lumena Pharmaceuticals, Inc., 12531 High Bluff Drive, Suite 110, San Diego, CA
Signature
/s/ Maria Dobek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alana B. McNulty:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Director Common Stock 2.5K $137K $54.75 Jun 26, 2024 Direct
eFFECTOR Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 150K Jun 20, 2022 Direct
Janux Therapeutics, Inc. Director Stock Option (right to buy) 8.35K Jun 26, 2024 Direct

Insider Reports Filed by Alana B. McNulty

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jun 26, 2024 2 $0 4 Jun 28, 2024 Director
GFOR NKGen Biotech, Inc. Sep 29, 2023 0 $0 3 Oct 10, 2023 Director
JANX Janux Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Jun 20, 2022 1 $0 4 Jun 22, 2022 Chief Business Officer
JANX Janux Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Jan 20, 2022 1 $0 4 Jan 24, 2022 Chief Business Officer
JANX Janux Therapeutics, Inc. Sep 7, 2021 1 $0 4 Sep 9, 2021 Director
JANX Janux Therapeutics, Inc. Sep 7, 2021 0 $0 3 Sep 9, 2021 Director
EFTR eFFECTOR Therapeutics, Inc. Aug 25, 2021 9 $0 4 Aug 27, 2021 Chief Business Officer
EFTR eFFECTOR Therapeutics, Inc. Aug 25, 2021 0 $0 3 Aug 27, 2021 Chief Business Officer